{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Columbus",
      "state": "OH",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90677",
      "recalling_firm": "Amerisource Health Services LLC",
      "address_1": "2550 John Glenn Ave Ste A",
      "address_2": "",
      "postal_code": "43217-1188",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the USA",
      "recall_number": "D-1349-2022",
      "product_description": "Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by:  Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 India.  Manufactured for BluePoint Laboratories.  NDC 68001-0313-56",
      "product_quantity": "4,160  vials",
      "reason_for_recall": "Subpotent Drug",
      "recall_initiation_date": "20220727",
      "center_classification_date": "20220817",
      "termination_date": "20230928",
      "report_date": "20220824",
      "code_info": "Lot #: FE22001A, Exp. Date 01/2024",
      "more_code_info": ""
    }
  ]
}